Anti-EEF1A2 antibody [EPR22651-46]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal EEF1A2 antibody. Suitable for IP, WB and reacts with Human, Mouse, Rat samples. Cited in 2 publications.
View Alternative Names
EEF1AL, STN, EEF1A2, Elongation factor 1-alpha 2, EF-1-alpha-2, Eukaryotic elongation factor 1 A-2, Statin-S1, eEF1A-2
- IP
Unknown
Immunoprecipitation - Anti-EEF1A2 antibody [EPR22651-46] (AB227824)
EEF1A2 was immunoprecipitated from 0.35 mg HEK-293T (human embryonic kidney epithelial cell) whole cell lysate with ab227824 at 1/30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab227824 1/1000 dilution (0.54 μg/ml). VeriBlot for IP Detection Reagent (HRP) (ab131366) was used as the secondary antibody at 1/5000 dilution.
Lane 1 : HEK-293T (human embryonic kidney epithelial cell) whole cell lysate 10μg
Lane 2 : ab227824 IP in HEK-293T whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab227824 in HEK-293T whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 15 seconds
All lanes:
Immunoprecipitation - Anti-EEF1A2 antibody [EPR22651-46] (ab227824)
Predicted band size: 47 kDa,50 kDa
Observed band size: 46 kDa,50 kDa
false
- WB
Unknown
Western blot - Anti-EEF1A2 antibody [EPR22651-46] (AB227824)
ab227824 was shown to specifically react with EEF1A2 in wild-type HAP1 cells as signal was lost in EEF1A2 knockout cells. Wild-type and EEF1A2 knockout samples were subjected to SDS-PAGE. ab227824 and ab181602 (Rabbit anti-GAPDH loading control) were incubated 1 hour at room temperature at 1/1000 dilution and 1/200,000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary antibody at 1/100,000 dilution for 1 hour at room temperature before imaging. The blot was developed on a BIO-RAD® ChemiDoc™ MP instrument using the ECL technique.
This antibody also recognizes a weakly unidentifiable band at around 75kDa
Blocking/diluting buffer and concentration : 5% NFDM/TBST
Exposure time : 3.25 seconds
All lanes:
Western blot - Anti-EEF1A2 antibody [EPR22651-46] (ab227824) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
EEF1A2 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HEK-293T (human embryonic kidney epithelial cell), whole cell lysate at 20 µg
Lane 4:
Neuro-2a (mouse neuroblastoma neuroblast), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 50 kDa
Observed band size: 50 kDa
false
- WB
Unknown
Western blot - Anti-EEF1A2 antibody [EPR22651-46] (AB227824)
Blocking/diluting buffer and concentration : 5% NFDM/TBST
Exposure time : 7.75 seconds
All lanes:
Western blot - Anti-EEF1A2 antibody [EPR22651-46] (ab227824) at 1/1000 dilution
All lanes:
Human brain tissue lysate at 20 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 50 kDa
Observed band size: 50 kDa
false
- WB
Unknown
Western blot - Anti-EEF1A2 antibody [EPR22651-46] (AB227824)
Blocking/diluting buffer and concentration : 5% NFDM/TBST
Exposure Time : 3.25 seconds
All lanes:
Western blot - Anti-EEF1A2 antibody [EPR22651-46] (ab227824) at 1/1000 dilution
Lane 1:
Mouse brain tissue lysate at 20 µg
Lane 2:
Mouse heart tissue lysate at 20 µg
Lane 3:
Rat brain tissue lysate at 20 µg
Lane 4:
Rat heart tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 50 kDa
Observed band size: 50 kDa
false
Related conjugates and formulations (1)
-
Anti-EEF1A2 antibody [EPR22651-46] - BSA and Azide free
Reactivity data
Product details
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EF1A2 supports cellular proliferation and growth by ensuring the continuous efficiency of protein synthesis. It participates in several protein complexes that are involved in translational control. By regulating the actin cytoskeleton EF1A2 additionally influences cell shape and motility. This multifunctionality indicates EF1A2's relevance in various cellular activities beyond its primary role in translation elongation.
Pathways
EF1A2 integrates into the protein synthesis pathway and also plays a role in the mTOR signaling pathway which regulates cell growth and metabolism. In the mTOR pathway EF1A2 works alongside other elongation factors like EF2 and components of the translation machinery to coordinate protein synthesis. It interacts with proteins involved in nutrient signaling and energy status showing its role in integrating metabolic signals with translational processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Journal of extracellular vesicles 13:e12409 PubMed38321535
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 8:15 PubMed35013140
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com